LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 39 of 497
Next
>>
>
951 to 975 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PLX-4720	0.37	uM	LJP5	3	K04	72	hr	1657	5464	5505	0.9924	0.9892
BT-20	QL-X-138	0.37	uM	LJP6	1	F22	72	hr	1657	3345	5505	0.6076	0.4385
BT-20	QL-X-138	0.37	uM	LJP6	2	F22	72	hr	1657	3708	5505	0.6735	0.5328
BT-20	QL-X-138	0.37	uM	LJP6	3	F22	72	hr	1657	3923	5505	0.7125	0.5887
BT-20	QL-XII-47	0.37	uM	LJP6	1	O22	72	hr	1657	2905	5505	0.5276	0.3241
BT-20	QL-XII-47	0.37	uM	LJP6	2	O22	72	hr	1657	3056	5505	0.5551	0.3634
BT-20	QL-XII-47	0.37	uM	LJP6	3	O22	72	hr	1657	2969	5505	0.5393	0.3408
BT-20	Radicicol	0.37	uM	LJP5	1	K10	72	hr	1657	2265	5505	0.4114	0.1578
BT-20	Radicicol	0.37	uM	LJP5	2	K10	72	hr	1657	2273	5505	0.4129	0.1599
BT-20	Radicicol	0.37	uM	LJP5	3	K10	72	hr	1657	2180	5505	0.3960	0.1357
BT-20	Radicicol	0.37	uM	LJP6	1	K10	72	hr	1657	2282	5505	0.4145	0.1622
BT-20	Radicicol	0.37	uM	LJP6	2	K10	72	hr	1657	2268	5505	0.4119	0.1586
BT-20	Radicicol	0.37	uM	LJP6	3	K10	72	hr	1657	2203	5505	0.4001	0.1417
BT-20	Seliciclib	0.37	uM	LJP5	1	J04	72	hr	1657	5298	5505	0.9623	0.9460
BT-20	Seliciclib	0.37	uM	LJP5	2	J04	72	hr	1657	5240	5505	0.9518	0.9310
BT-20	Seliciclib	0.37	uM	LJP5	3	J04	72	hr	1657	5100	5505	0.9263	0.8946
BT-20	Ruxolitinib	0.37	uM	LJP5	1	O16	72	hr	1657	5057	5505	0.9185	0.8834
BT-20	Ruxolitinib	0.37	uM	LJP5	2	O16	72	hr	1657	5256	5505	0.9547	0.9351
BT-20	Ruxolitinib	0.37	uM	LJP5	3	O16	72	hr	1657	5103	5505	0.9269	0.8954
BT-20	XL147	0.37	uM	LJP5	1	G10	72	hr	1657	5458	5505	0.9913	0.9876
BT-20	XL147	0.37	uM	LJP5	2	G10	72	hr	1657	5317	5505	0.9657	0.9510
BT-20	XL147	0.37	uM	LJP5	3	G10	72	hr	1657	5416	5505	0.9837	0.9767
BT-20	Saracatinib	0.37	uM	LJP6	1	D10	72	hr	1657	4952	5505	0.8994	0.8561
BT-20	Saracatinib	0.37	uM	LJP6	2	D10	72	hr	1657	4573	5505	0.8306	0.7576
BT-20	Saracatinib	0.37	uM	LJP6	3	D10	72	hr	1657	5157	5505	0.9367	0.9094

|<
<<
Previous
Page 39 of 497
Next
>>
>
951 to 975 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)